DJIA 18,078.63 48.42 0.27%
NASDAQ 4,800.69 27.21 0.57%
S&P 500 2,090.68 8.80 0.42%
market minute promo

Isis Pharmaceuticals (NASDAQ: ISIS)

63.45 3.96 (6.66%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ISIS $63.37 6.52%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $61.20
Previous Close $59.49
Daily Range $61.00 - $63.87
52-Week Range $22.25 - $67.12
Market Cap $7.5B
P/E Ratio -72.55
Dividend (Yield) $0.00 (0.0%)
Volume 1,366,218
Average Daily Volume 2,861,212
Current FY EPS -$0.53

Sector

Healthcare

Industry

Drugs

Isis Pharmaceuticals (ISIS) Description

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. Website: http://www.isispharm.com/

News & Commentary

3 Drugmakers Facing a Pivotal 2015

Isis Pharmaceuticals, PTC Therapeutics, and GW Pharmaceuticals all expect 2015 to be a pivotal year in their drive toward becoming commercially viable entities. Should investors jump in before the catalysts spark?

Isis Pharmaceuticals (ISIS) Showing Signs Of A Dead Cat Bounce Today

Biotech Stocks Sell Off, ETFs Fall Over 5%

Worst Performing Industries For December 23, 2014

Mid-Morning Market Update: Markets Mostly Higher; Walgreen Profit Beats Expectations

Isis Pharmaceuticals (ISIS) Stock: Weak On High Volume Today

Why Isis Pharmaceuticals (ISIS) Stock Might be a Great Pick - Tale of the Tape

Why Isis Pharmaceuticals (ISIS) Stock Might be a Great Pick - Tale of the Tape

IWM, HEZU: Big ETF Inflows

Cramer: ‘Downside’ to Biotech as ImmunoGen Stock Cut in Half

Jim Cramer's Top Stock Picks: BA MMM ISIS Q

See More ISIS News...

ISIS's Top Competitors

ISIS $63.45 (6.66%)
Current stock: ISIS
AMGN $162.86 (1.36%)
Current stock: AMGN
GILD $93.61 (2.54%)
Current stock: GILD
BIIB $341.61 (0.21%)
Current stock: BIIB